Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

Assam's Health Minister, Ashok Singhal, urged government doctors to prescribe hospital pharmacy and generic medicines to ...

ANI is offering prucalopride tablets, which is the generic of Takeda's Motegrity. Motegrity is used in adults to treat chronic idiopathic constipation. "We are delighted to build momentum early in ...

The launch of a generic version of Novartis's (NYSE:NVS) blockbuster cardiac drug Entresto has reportedly been temporarily blocked by a federal appeals court as it considers the drugmaker's ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Here’s more about this ...

A U.S. appeals court has lifted a temporary halt it imposed on the launch of a generic version of Novartis's (NYSE:NVS) top-selling cardiac drug Entresto. The U.S. Court of Appeals for the ...

This marks the 6th overall ANDA approval for A.forall and another instance where Competitive Generic Therapy (CGT) eligibility has been granted. Moreover, Milla Pharmaceuticals is commercializing ...

WASHINGTON, Jan 16 - Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis' blockbuster heart-failure drug Entresto after a U.S. appeals ...

Q: Three nights in a row, I have seen a medicine commercial on TV that features a car with no nameplate of any kind, front, back or side. The car is obviously an orange 1964 and a half Mustang.

WASHINGTON -A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis (SIX:NOVN)' blockbuster heart-failure drug Entresto late on Wednesday.

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...